Early risers on Sunday morning have paid tribute to Prince Philip outside Windsor Castle as the country continues its period of national mourning.
Early risers on Sunday morning have paid tribute to Prince Philip outside Windsor Castle as the country continues its period of national mourning.
(Bloomberg) -- China’s securities regulator is weighing tighter rules for companies seeking to list in Hong Kong or overseas, a move that could hit technology firms already smarting from months of clampdowns, according to people familiar with the matter.The China Securities Regulatory Commission is considering proposals that would require firms seeking initial public offerings outside mainland China to submit listing documents to ensure they’re compliant with local laws and regulations, the people said. The scrutiny would also seek to prevent any leaks of sensitive data that might be of national security interest, the people added, requesting they not be identified as the matter is private. The discussions are preliminary and could be subject to change.When asked if it was considering such changes, the CSRC issued a brief denial without elaborating.The heightened regulatory concerns come as the U.S. tightens restrictions on Chinese firms listed on its exchanges, with legislation that requires the companies to allow inspectors to review their financial audits. China has long refused to let the U.S. Public Company Accounting Oversight Board examine audits of firms whose shares trade in America, citing national security interests.The measures, if rolled out, could have far-reaching implications for a raft of upstarts that are on the verge of going public. Among them are Bytedance Ltd., which is said to be weighing a listing of some of its China units, and ride-hailing giant Didi Chuxing, people familiar have said. The changes could also ensnare Chinese firms that already trade in foreign markets, requiring them to submit filings to regulators as well, one of the people said.China’s current rules require all locally registered companies and some firms with offshore registrations to seek approval from the securities watchdog when they list in Hong Kong or outside the country. However, many internet stars like Tencent Holdings Ltd. and Alibaba Group Holding Ltd., registered in places like Cayman Islands or the British Virgin Islands, fall outside the scope of the current regulations. The new rules would seek to lay out more specific reporting guidelines and standardize them across firms, one of the people said.It is unclear what impact any news rules may have for companies that operate a so-called Variable Interest Entity -- a vehicle through which virtually every major Chinese internet company attracts foreign investment and lists overseas.Regulators have issued a slew of measures placing greater scrutiny on the nation’s tech giants, curtailing their operations on everything from data collection and monopolistic practices. Among the orders issued by financial regulators in April were new guidelines on securitizing assets and seeking overseas listings.China has already tightened measures for listings on domestic exchanges including Shanghai’s Nasdaq-style Star board. It’s restricted listings of fintech companies, and banned IPOs by firms that operate mainly in real estate and sectors related to financial investment.The clampdown on tech firms led to the postponement of a $35 billion IPO by Jack Ma’s Ant Group Co. in November. On orders from regulators, Ant must drastically revamp its business and will be supervised more like a bank, a move with far-reaching implications for its growth.(Updates with CSRC comment in third paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
The company said that it is ready for take-off but called on the UK government to include four measures to "enable a safe reopening" of travel.
The hotel chain, which also includes Holiday Inn and Crowne Plaza, saw mixed results in Europe due to travel restrictions remaining in place.
(Bloomberg) -- EXAMPLEDiscover what’s driving the global economy and what it means for policy makers, businesses, investors and you with The New Economy Daily. Sign up here.In the pandemic’s second year, some familiar worries -- about inflation, capital flight or public debt -- are starting to surface across the developing world. Except in one corner.In Asia, policy makers aren’t too preoccupied with these classic emerging-market problems. Their economies look increasingly like they’ve emerged.That’s largely down to lessons learned from the traumas of the past three decades –- from the late-1990s regional meltdown to the global crash of 2008 and the so-called “taper tantrum” of 2013 -- and the defenses put in place as a result.“Asian countries have used past crises to learn and build resilience,” said Sonal Varma, an economist at Nomura Holdings Inc. in Singapore.Their economies now boast hefty foreign-exchange reserves, stronger financial systems and an unassailable place as the world’s manufacturing powerhouse. Their stock markets, like those in the developed world, have posted gains during the pandemic while other emerging regions lost ground.In India, which is battling the world’s worst Covid-19 outbreak, the central bank chief has cited the buffer provided by its foreign exchange reserves, which have grown more than tenfold since 2000. “This gives us the confidence to deal with global spillovers,” Governor Shaktikanta Das said Wednesday as he introduced new support measures.Similarly, Indonesia and Thailand’s reserves are holding near records after expanding more than five- and seven-fold, respectively, over that period.All of this has left the region’s policymakers largely unfazed by the great inflation scare roiling many of their peers.With U.S. bond yields on the rise and the prices of food, energy and raw materials soaring, emerging nations like Brazil, Russia and Turkey have been forced into interest-rate hikes this year -– even though their economies are still recovering from Covid-19.By contrast, central bankers in Asia sound more like the Federal Reserve’s Jerome Powell -- arguing that any price increases will likely be modest and transitory. No emerging Asia economy has raised their benchmark interest rate so far in 2021, and only Pakistan is forecast to do so by year-end, according to Bloomberg.The region is likely to undershoot inflation targets this year like it did in 2020, TD Ameritrade analysts said in an April 19 report.Lessons LearnedAt the start of the Asian crisis in 1997, policymakers responded with fiscal consolidation and higher interest rates. The ensuing slump cost the region hundreds of billions of dollars in lost output and triggered a profound rethink of how economies should be managed.When the global crash of 2008 arrived, Asian economies were more resilient “because they responded with countercyclical fiscal and monetary stimulus,” according to a report this year by the United Nations Economic and Social Commission for Asia and the Pacific. And there’s been no major debt crisis in the region since the 90s, “thanks in part to the rapid growth of local currency bond markets.”The markets for government and corporate debt in emerging Asian economies were worth more than $20 trillion last year, up from less than $1 trillion two decades earlier.Some countries also moved to impose long-term restraints on spending -- like Indonesia, which enshrined a budget-deficit cap equal to 3% of GDP in law. When the rule was broken during the pandemic, investors broadly accepted the assurance that it would be reinstated when the emergency was past.On debt vulnerabilities and other metrics, Asian economies generally rank the strongest in Bloomberg’s emerging-market scorecard.Trade has given Asia an extra buffer throughout the pandemic, as its exports bounced back relatively fast. South Korea and Taiwan, the key suppliers to a tight global market for semiconductors, are in an especially strong position.For some analysts, those economies -- where per-capita economic output is around $30,000 -- are too wealthy to be considered emerging markets anyway. That highlights a wider problem with the term, which evolved to describe a class of financial assets and doesn’t capture distinctions between economies and societies.The group known as Emerging Asia often includes giant but poorer economies like India, as well as much richer ones like Taiwan. Others on the widely-used MSCI EM Asia index include Indonesia, South Korea, Malaysia, Pakistan, Philippines and Thailand -- as well as China, which many in the financial world place in a category of its own.‘Sigh of Relief’Whatever the labels, the proximity of the world’s fastest-growing large economy has been a boon for neighbors, especially in the pandemic.Around the middle of last year, many Asian companies “were facing sudden stops in orders and liquidity,” said Taimur Baig, chief economist at DBS Bank Ltd. in Singapore. “As China’s factories began to hum, a sigh of relief percolated through Asia’s elaborate supply chain.”Many emerging-market investors already treat Asia differently. Ian Samson, a fund manager at Fidelity International in Hong Kong, says it’s in effect a separate bloc.“In terms of the fundamentals -- whether it’s structural growth or fiscal balances -- Asia has been outperforming Latin America” and emerging markets in Europe, Africa and the Middle East, Samson said. Asia is especially dominant in emerging-market equities, accounting for the large majority of total investment, he said -- partly because it has bigger companies, and partly because more of them are in high-growth sectors like technology.Paul Sandhu at BNP Paribas Asset Management sees Asian out-performance continuing “for the foreseeable future” -- and he points to strengths that go beyond economics to include governance. In the early phases of the pandemic, Asia “handled it better than any other economy, whether in emerging markets or developed markets,” he said.To be sure, Asia has its share of problems. Beyond India’s deadly second wave of Covid-19 infections, there have been resurgences in Thailand and the Philippines too, while vaccination campaigns are lagging.Other economic challenges include escalating private debt and longer-run question marks over central-bank independence -- issues that trouble some developed economies too. And the growing tensions between the U.S. and China create headaches for countries seeking to stay on good terms with both.Still, the region’s economies generally have more room for error than most of their counterparts, according to Baig at DBS.“No emerging economy in Asia at present is characterized by debt sustainability concerns or a dramatic collapse in investor sentiment, which seems to be the case in a number of emerging economies elsewhere,” said Baig.(Updates to add Indonesia and Thailand foreign currency reserves in seventh paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
The Belgian has been the target of displeasure after the Spanish side were easily beaten in midweek
Disney Channel sitcom made Duff a star as a teenager
Dublin, May 07, 2021 (GLOBE NEWSWIRE) -- The "Virtual Reality Market Global Forecast by Software Application, Regions, End Users Hardware, Company Analysis" report has been added to ResearchAndMarkets.com's offering. The Global Virtual Reality Market will be USD 80.16 Billion by the end of 2026, from USD 23.70 Billion in the year 2020 Virtual Reality (VR) is a technology that produces a 3D computer-based environment where a person can traverse, inter-connect and participate in the unrealistic world. The Virtual Reality Marketing strategy changes the way products and services are developed and delivered, further transforming into increased productivity and operational efficiencies across domains like Live Events, Video Entertainment, Videogames, Education, Retail, Healthcare, Military, Engineering and Real Estate. Globally, Virtual Reality is likely to have multiple advanced applications for both consumer and enterprise in the coming years.In this report, The publisher has bifurcated the Virtual Reality Market into hardware and software. The virtual reality hardware market constitutes sensors in the headset, which stalks the user's motion and switches the user's perspective accordingly. Besides, it also gives users the apprehension of physical omnipresence in that environment.Learning and training and scientific visualization are amongst the most vital applications of virtual reality technology. It diminishes the investments and brings enhancement across a wide range of industries to provide extreme training situations. It is used for education purposes in several industries, including healthcare, machine operations, and corporate training. Besides, it also reduces the training budget in the form of equipment durability and logistics rebate.In the year 2020, with the outbreak of COVID-19, Virtual Reality played a vital role in offering a comprehensive platform. The pop has led to a rise in virtual tech conferences and meet-ups since several organizations have cancelled their events and meetings. As an occurrence, tech giant Microsoft has announced to organize all its events digitally until July 2021, including its flagship Microsoft Ignite and Microsoft Build 2020.Regional AnalysisEurope has gained eminence over the past years due to the development and launch of innovative VR headsets targeted primarily at the region's gaming community. However, advancements in immersive technology have widened the scope of technology in several applications. The VR segment is growing, consumers are showing interest, and industry leaders recognize these areas as a potential opportunity for growth in the region. As per the research analysis, Global Virtual Reality Industry is expected to grow with a double-digit CAGR of 22.52% from 2020 to 2026.Similarly, in the Asia Pacific region, Japan has introduced 5G commercial services in 2019, which has led to telecommunication companies' strategic initiatives to offer VR viewing platforms utilizing 5G connectivity. Furthermore, the governments' favourable initiatives, such as funds and investments to support VR companies, also boost virtual reality technology enactment in the region. This unique and useful benefit anticipates to build-up the market for Virtual Reality in the coming years.This report has analyzed the competitive landscape and provided the key players' profiles such as Sony, Facebook (Oculus) and HTC. This market research report provides a complete analysis of the Global Virtual Reality Market Growth Drivers, Challenges, and projections from 2021 to 2026. Key Topics Covered: 1. Introduction2. Research & Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Global Virtual Reality Market6. Market Share6.1 Software vs. Hardware6.2 Software Market Share by Application6.3 Software Market Share by Region6.4 Hardware Market Share by End User6.5 Hardware Market Share by Country7. Software Application Market7.1 Videogames7.2 Live Events7.3 Video Entertainment7.4 Real Estate7.5 Retail7.6 Education7.7 Healthcare7.8 Engineering7.9 Military8. Software Region Market8.1 North America8.2 Latin America8.3 Europe8.4 Asia8.5 Rest of world9. End User Hardware Market9.1 Consumer9.2 Enterprise10. Country Hardware Market10.1 China10.2 Japan10.3 United States10.4 Europe11. Volume - Virtual Reality Head Mounted Display (HMD)12. Company Analysis12.1 Sony12.1.1 Company Overview12.1.2 Exposure / Initiatives to Virtual Reality12.1.3 Sales Analysis12.2 Oculus12.2.1 Company Overview12.2.2 Exposure / Initiatives to Virtual Reality12.2.3 Facebook VR Sales Analysis12.3 HTC12.3.1 Company Overview12.3.2 Exposure / Initiatives to Virtual Reality12.3.3 HTC VR Sales Analysis For more information about this report visit https://www.researchandmarkets.com/r/3gt8zl CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Face masks for English secondary school pupils to be ditched, Williamson confirms. Education secretary says lockdown easing measure will go ahead despite protests from unions and others
Build-up to super middleweight main event has become increasingly intense this week
Boris Johnson was described as a “remarkable election winner” by a top local government expert today after the Tories took Hartlepool in an historic by-election. Professor Tony Travers described Labour’s performance in the set of elections as “unprecedented” and explained that former UKIP voters appeared to be moving to the Tories.
Nancy Mitford is not the frothy romance novelist that many think, but an accomplished writer who understood how dark life can be
Material had previously been shared unofficially on SoundCloud
Clanton played season five regular Savino Bratton
As Nancy Mitford’s The Pursuit of Love comes to the BBC, we look at how the legacy of the Mitford sisters continues to fascinate
The revival was abandoned last year.
Sam Simmonds is included while Johnny Sexton and Kyle Sinckler were surprising omissions
Romance! Gorgeous costumes! Brooding glances! As we await the BBC’s new adaptation of The Pursuit of Love, we pick our faves
Dublin, May 07, 2021 (GLOBE NEWSWIRE) -- The "Regenerative Medicine for Cartilage Global Market Report 2021: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.The global regenerative medicine for cartilage market is expected to grow from $4.47 billion in 2020 to $4.83 billion in 2021 at a compound annual growth rate (CAGR) of 8.10%.Major players in the regenerative medicine for cartilage market are B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith & Nephew plc, Arthrex Inc., CONMED Corporation, Collagen Solutions PLC, BioTissue Technologies, CellGenix, Osiris Therapeutics Inc., and DePuy Synthes. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $6.56 billion in 2025 at a CAGR of 7.94%.The main types of regenerative medicine for cartilage are cell-based and non-cell-based. The type of treatment includes palliative and intrinsic repair stimulus among others that are used by ambulatory surgical centers, hospitals and clinics, and surgical centers. The regenerative medicine for cartilage is used for hyaline cartilage repair and regeneration, elastic cartilage repair and regeneration, and fibrous cartilage repair and regeneration.Europe was the largest region in regenerative medicine for cartilage in 2020. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.The high cost of regenerative medicine therapies is one of the major factors limiting the growth of the market for regenerative medicine for cartilage. The average cost for knee replacement is around $4,500 to $8,400, while the average cost of cartilage repair procedures is around $18,000, depending on the country where the procedure is being performed. Such high prices discourage individuals to resort to cartilage repair therapies, and in turn, result in a lower preference for these procedures.In April 2019, Smith & Nephew plc, a UK-based multinational medical equipment manufacturing company, acquired Osiris Therapeutics, Inc. for approximately $660 million. The acquisition is expected to stimulate growth from Smith & Nephew's advanced wound management franchise. Osiris Therapeutics, Inc. is a US-based company that researches and develops therapeutic products for the regeneration of human connective tissues.The growing incidence of osteoarthritis across the globe will drive the market for regenerative medicine for cartilage. Osteoarthritis is a degenerative joint disorder that mostly attacks the articular cartilage. According to the Arthritis Foundation in 2019, degenerative joint disease disorders such as osteoarthritis will impact at least 130 million individuals around the globe by 2050. Some of the most commonly used treatments for osteoarthritis are autologous chondrocyte implantation and scaffold implants. Thus, the increasing incidence of osteoarthritis is expected to drive the demand for the market for regenerative medicine for cartilage.Tissue engineering and stem cell therapy are emerging trends in the regenerative medicine for cartilage market. The growth of tissue engineering technology has given hope for the regeneration of cartilage. Stem cell therapy is gaining attention with its advantages over traditional orthopedic treatments. Stem cell therapy helps to reduce knee pain and improves knee cartilage regeneration and repair. For instance, growth factors in the form of platelet-rich plasma (PRP) therapy are injected to promote tissue regeneration effectively. Companies operating in the market are continuously focusing on introducing new technologies to survive in the regenerative medicine for cartilage market.Key Topics Covered: 1. Executive Summary 2. Regenerative Medicine for Cartilage Market Characteristics 3. Regenerative Medicine for Cartilage Market Trends and Strategies 4. Impact of COVID-19 on Regenerative Medicine for Cartilage 5. Regenerative Medicine for Cartilage Market Size and Growth 5.1. Global Regenerative Medicine for Cartilage Historic Market, 2015-2020, $ Billion5.1.1. Drivers of the Market 5.1.2. Restraints on the Market 5.2. Global Regenerative Medicine for Cartilage Forecast Market, 2020-2025F, 2030F, $ Billion5.2.1. Drivers of the Market 5.2.2. Restraints on the Market 6. Regenerative Medicine for Cartilage Market Segmentation 6.1. Global Regenerative Medicine for Cartilage Market, Segmentation by Treatment Modality, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion Cell-BasedNon-Cell-Based 6.2. Global Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion PalliativeIntrinsic Repair StimulusOthers 6.3. Global Regenerative Medicine for Cartilage Market, Segmentation by Site, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion Knee Cartilage RepairRibsOthers 6.4. Global Regenerative Medicine for Cartilage Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion Hyaline Cartilage Repair and RegenerationElastic Cartilage Repair and RegenerationFibrous Cartilage Repair and Regeneration 6.5. Global Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion Ambulatory Surgical CentersHospitals & ClinicsSurgical CentersOthers 7. Regenerative Medicine for Cartilage Market Regional and Country Analysis 7.1. Global Regenerative Medicine for Cartilage Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion7.2. Global Regenerative Medicine for Cartilage Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion Companies Mentioned B. Braun Melsungen AGZimmer Biomet Holdings Inc.Vericel CorporationStryker CorporationSmith & Nephew plcArthrex Inc.CONMED CorporationCollagen Solutions PLCBioTissue TechnologiesCellGenixOsiris Therapeutics Inc.DePuy Synthes For more information about this report visit https://www.researchandmarkets.com/r/1ynr2m CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Follow all the latest developments
The South Carolina senator reached new heights in his Trump adulation.